NBE Therapeutics
is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer... Read moreNBE Therapeutics
is a biotechnology company that develops and commercializes antibody-drug conjugates for the treatment of cancer... Read more
CEO
Add
News
Apr 04, 2025
Pharamceutical Technology
NBE Therapeutics: NBE Therapeutics opens ADC research facility in Switzerland
Apr 03, 2025
The Korea Bizwire
NBE Therapeutics: Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
Dec 15, 2020
PMLiVE
NBE Therapeutics: Boehringer spends 1.18bn to acquire NBE-Therapeutics
Dec 11, 2020
PharmaLeaders
NBE Therapeutics: Boehringer to acquire Swiss biotech company NBE-Therapeutics for 1.18bn
Dec 10, 2020
BioSpace
NBE Therapeutics: Acquisition Agreement with Boehringer Ingelheim for NBE-Therapeutics Marks First Major Biotech Exit for PPF Group
Dec 10, 2020
startupticker
NBE Therapeutics: NBE Therapeutics makes a 1.18 billion exit
Dec 10, 2020
BioPharma Dive
NBE Therapeutics: Boehringer goes after antibody cancer drugs in latest acquisition
Oct 28, 2020
startupticker
NBE Therapeutics: NBE-Therapeutics launches first clinical trials
Oct 27, 2020
Pharmabiz
NBE Therapeutics: NBETherapeutics begins phase 1/2 study of antiROR1 ADC, NBE002 to treat solid tumors
Sep 10, 2020
Pharmabiz
NBE-Therapeutics: Exelixis, NBETherapeutics partner to develop novel antibodydrug conjugates for cancer treatment
NBE Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10